CD274 and cervical carcinoma: A retrospective analysis of non-immunotherapy-treated patients with advanced cervical cancer revealed a higher prevalence of PD-L1 CPS ≥1 (48), suggesting that PD-L1 positive patients tend to present at more advanced stages of the disease (43).